C1ORF103 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.993000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.948000E-01
Normal-vs-Stage2
3.962000E-01
Normal-vs-Stage3
2.587800E-01
Normal-vs-Stage4
8.744600E-01
Stage1-vs-Stage2
7.399200E-01
Stage1-vs-Stage3
5.262500E-03
Stage1-vs-Stage4
6.173400E-01
Stage2-vs-Stage3
3.227900E-02
Stage2-vs-Stage4
5.626400E-01
Stage3-vs-Stage4
1.734240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.967800E-01
Normal-vs-AfricanAmerican
5.553800E-01
Normal-vs-Asian
3.850400E-01
Caucasian-vs-AfricanAmerican
9.914600E-01
Caucasian-vs-Asian
5.328800E-01
AfricanAmerican-vs-Asian
6.954000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.561600E-01
Normal-vs-Female
4.768600E-01
Male-vs-Female
6.145000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.134800E-01
Normal-vs-Age(41-60Yrs)
8.979800E-01
Normal-vs-Age(61-80Yrs)
2.160200E-01
Normal-vs-Age(81-100Yrs)
3.338400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.310600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.757600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.653400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.791800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.068980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.192600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.678400E-01
Normal-vs-Daily Drinker
7.954000E-01
Normal-vs-Weekly Drinker
4.798600E-01
Normal-vs-Occasional Drinker
8.537200E-01
Normal-vs-Social Drinker
6.755600E-01
Non Drinker-vs-Daily Drinker
4.643800E-02
Non Drinker-vs-Weekly Drinker
9.260000E-01
Non Drinker-vs-Occasional Drinker
1.387740E-02
Non Drinker-vs-Social Drinker
8.657900E-02
Daily Drinker-vs-Weekly Drinker
6.542100E-02
Daily Drinker-vs-Occasional Drinker
8.522000E-01
Daily Drinker-vs-Social Drinker
7.696000E-01
Weekly Drinker-vs-Occasional Drinker
3.966000E-02
Weekly Drinker-vs-Social Drinker
1.710580E-01
Occasional Drinker-vs-Social Drinker
6.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.226400E-01
Normal-vs-Grade 2
5.780000E-01
Normal-vs-Grade 3
8.335400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.437600E-01
Grade 1-vs-Grade 3
8.728000E-01
Grade 1-vs-Grade 4
7.226400E-01
Grade 2-vs-Grade 3
9.626400E-01
Grade 2-vs-Grade 4
5.780000E-01
Grade 3-vs-Grade 4
8.335400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.194400E-01
Normal-vs-NonDiabetic
5.145400E-01
Diabetic-vs-NonDiabetic
4.131900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.652400E-01
Normal-vs-NoPancreatitis
4.042800E-01
Pancreatitis-vs-NoPancreatitis
3.994000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.744400E-01
Normal-vs-N1
4.634600E-01
N0-vs-N1
1.362430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.126400E-01
Normal-vs-TP53-NonMutant
3.565600E-01
TP53-Mutant-vs-TP53-NonMutant
1.604180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
